These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37566428)

  • 1. Changes in Medicaid Fee-for-Service Benefit Design for Substance Use Disorder Treatment During the Opioid Crisis, 2014 to 2021.
    Shoulders A; Andrews CM; Westlake MA; Abraham AJ; Grogan CM
    JAMA Health Forum; 2023 Aug; 4(8):e232502. PubMed ID: 37566428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care.
    Abraham AJ; Andrews CM; Harris SJ; Westlake MM; Grogan CM
    JAMA Health Forum; 2022 Nov; 3(11):e224001. PubMed ID: 36331441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Medicaid Managed Care Coverage of Substance Use Services and Treatment Utilization.
    Auty SG; Cole MB; Wallace J
    JAMA Health Forum; 2022 Aug; 3(8):e222812. PubMed ID: 36218990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicaid coverage of medications to treat alcohol and opioid dependence.
    Mark TL; Lubran R; McCance-Katz EF; Chalk M; Richardson J
    J Subst Abuse Treat; 2015 Aug; 55():1-5. PubMed ID: 25921475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by medicare in 2021.
    Clemans-Cope L; Lynch V; Payton M; Aarons J
    Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):49. PubMed ID: 35794626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.
    Grogan CM; Andrews C; Abraham A; Humphreys K; Pollack HA; Smith BT; Friedmann PD
    Health Aff (Millwood); 2016 Dec; 35(12):2289-2296. PubMed ID: 27920318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
    Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
    JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.
    Burns RM; Pacula RL; Bauhoff S; Gordon AJ; Hendrikson H; Leslie DL; Stein BD
    Subst Abus; 2016; 37(1):63-9. PubMed ID: 26566761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of Medications for Opioid Use Disorder Among West Virginia Medicaid Enrollees Following Medicaid Coverage of Methadone.
    Harris SJ; Landis RK; Li W; Stein BD; Saloner B
    Subst Use Addctn J; 2024 Jan; 45(1):91-100. PubMed ID: 38258853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Most States Allow Medicaid Managed Care Plans Discretion To Restrict Substance Use Disorder Treatment Benefits.
    Peterson LA; Andrews CM; Abraham AJ; Westlake MA; Grogan CM
    Health Aff (Millwood); 2024 Jul; 43(7):1038-1046. PubMed ID: 38950296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis.
    Dickson-Gomez J; Weeks M; Green D; Boutouis S; Galletly C; Christenson E
    Drug Alcohol Depend Rep; 2022 Jun; 3():100051. PubMed ID: 36845978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act.
    Andrews CM; Grogan CM; Smith BT; Abraham AJ; Pollack HA; Humphreys K; Westlake MA; Friedmann PD
    Health Aff (Millwood); 2018 Aug; 37(8):1216-1222. PubMed ID: 30080460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do children receiving Supplemental Security Income who are enrolled in Medicaid fare better under a fee-for-service or comprehensive capitation model?
    Mitchell JM; Gaskin DJ
    Pediatrics; 2004 Jul; 114(1):196-204. PubMed ID: 15231928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
    Gertner AK; Robertson AG; Jones H; Powell BJ; Silberman P; Domino ME
    Health Serv Res; 2020 Jun; 55(3):383-392. PubMed ID: 32166761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicaid managed care restrictions on medications for the treatment of opioid use disorder.
    Stewart MT; Andrews CM; Feltus SR; Hodgkin D; Horgan CM; Thomas CP; Nong T
    Health Serv Res; 2024 Oct; ():. PubMed ID: 39390740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of County Opioid Epidemic Severity to Changes in Access to Substance Use Disorder Treatment, 2009-2017.
    Yarbrough CR; Abraham AJ; Adams GB
    Psychiatr Serv; 2020 Jan; 71(1):12-20. PubMed ID: 31575353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicaid Coverage for Methadone Maintenance and Use of Opioid Agonist Therapy in Specialty Addiction Treatment.
    Saloner B; Stoller KB; Barry CL
    Psychiatr Serv; 2016 Jun; 67(6):676-9. PubMed ID: 26927578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System.
    Abraham AJ; Yarbrough CR; Harris SJ; Adams GB; Andrews CM
    Psychiatr Serv; 2021 Feb; 72(2):148-155. PubMed ID: 33267651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in outpatient mental health service utilization under capitation.
    Chou AF; Wallace N; Bloom JR; Hu TW
    J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings.
    Meinhofer A; Hinde JM; Ali MM
    J Subst Abuse Treat; 2020 Mar; 110():9-17. PubMed ID: 31952630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.